2017 Q4 Form 10-K Financial Statement

#000143774919005421 Filed on March 21, 2019

View on sec.gov

Income Statement

Concept 2017 Q4 2017 2016 Q4
Revenue $4.830M $18.32M $7.250M
YoY Change -33.38% -33.09% -28.08%
Cost Of Revenue $2.800M $10.59M $4.980M
YoY Change -43.78% -47.48% -34.04%
Gross Profit $2.030M $7.725M $2.270M
YoY Change -10.57% 7.17% -9.92%
Gross Profit Margin 42.03% 42.18% 31.31%
Selling, General & Admin $1.580M $6.459M $1.850M
YoY Change -14.59% -20.74% -17.41%
% of Gross Profit 77.83% 83.61% 81.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $110.0K $481.0K $140.0K
YoY Change -21.43% -20.1% -6.67%
% of Gross Profit 5.42% 6.23% 6.17%
Operating Expenses $1.690M $6.459M $1.990M
YoY Change -15.08% -20.74% -16.74%
Operating Profit $340.0K $1.106M $280.0K
YoY Change 21.43% -274.72% 115.38%
Interest Expense -$100.0K $328.0K -$100.0K
YoY Change 0.0% -10.14% -9.09%
% of Operating Profit -29.41% 29.66% -35.71%
Other Income/Expense, Net $0.00 -$3.000K -$10.00K
YoY Change -100.0% -50.0% -200.0%
Pretax Income $250.0K $775.0K $170.0K
YoY Change 47.06% -177.19% 325.0%
Income Tax $10.00K $9.000K $20.00K
% Of Pretax Income 4.0% 1.16% 11.76%
Net Earnings $239.0K $766.0K $150.0K
YoY Change 59.33% -174.88% 650.0%
Net Earnings / Revenue 4.95% 4.18% 2.07%
Basic Earnings Per Share $0.05
Diluted Earnings Per Share $0.02 $0.05 $0.01
COMMON SHARES
Basic Shares Outstanding 15.51M 15.65M shares
Diluted Shares Outstanding 16.52M

Balance Sheet

Concept 2017 Q4 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.270M $2.268M $2.150M
YoY Change 5.58% 5.39% 90.27%
Cash & Equivalents $2.268M $2.268M $2.152M
Short-Term Investments
Other Short-Term Assets $330.0K $337.0K $790.0K
YoY Change -58.23% -57.4% -40.15%
Inventory $134.0K $134.0K $59.00K
Prepaid Expenses
Receivables $990.0K $990.0K $2.390M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.729M $3.729M $5.391M
YoY Change -30.83% -30.83% -43.34%
LONG-TERM ASSETS
Property, Plant & Equipment $418.0K $418.0K $544.0K
YoY Change -23.16% -23.16% -22.51%
Goodwill $1.907M $1.907M
YoY Change 0.0% 0.0%
Intangibles $561.0K $704.0K
YoY Change -20.31% -16.29%
Long-Term Investments
YoY Change
Other Assets $112.0K $112.0K $30.00K
YoY Change 273.33% 273.33% 0.0%
Total Long-Term Assets $2.998M $2.998M $3.185M
YoY Change -5.87% -5.87% -8.48%
TOTAL ASSETS
Total Short-Term Assets $3.729M $3.729M $5.391M
Total Long-Term Assets $2.998M $2.998M $3.185M
Total Assets $6.727M $6.727M $8.576M
YoY Change -21.56% -21.56% -34.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.413M $2.841M $3.652M
YoY Change -61.31% -46.59% -52.01%
Accrued Expenses $847.0K $1.053M
YoY Change -19.56% -32.59%
Deferred Revenue $2.494M
YoY Change
Short-Term Debt $0.00 $0.00 $740.0K
YoY Change -100.0% -100.0% -65.58%
Long-Term Debt Due $0.00 $246.0K
YoY Change -100.0% -14.29%
Total Short-Term Liabilities $5.335M $5.335M $9.120M
YoY Change -41.5% -41.5% -27.16%
LONG-TERM LIABILITIES
Long-Term Debt $1.656M $1.656M $825.0K
YoY Change 100.73% 100.73% -20.37%
Other Long-Term Liabilities $41.00K $41.00K $62.00K
YoY Change -33.87% -33.87% 67.57%
Total Long-Term Liabilities $1.697M $1.697M $887.0K
YoY Change 91.32% 91.32% -17.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.335M $5.335M $9.120M
Total Long-Term Liabilities $1.697M $1.697M $887.0K
Total Liabilities $7.032M $7.032M $10.01M
YoY Change -29.73% -29.73% -26.39%
SHAREHOLDERS EQUITY
Retained Earnings -$67.66M -$68.42M
YoY Change -1.12% 1.52%
Common Stock $2.000K $2.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.536M $1.532M
YoY Change 0.26% 0.07%
Treasury Stock Shares $769.0K $748.0K
Shareholders Equity -$305.0K -$305.0K -$1.431M
YoY Change
Total Liabilities & Shareholders Equity $6.727M $6.727M $8.576M
YoY Change -21.56% -21.56% -34.0%

Cashflow Statement

Concept 2017 Q4 2017 2016 Q4
OPERATING ACTIVITIES
Net Income $239.0K $766.0K $150.0K
YoY Change 59.33% -174.88% 650.0%
Depreciation, Depletion And Amortization $110.0K $481.0K $140.0K
YoY Change -21.43% -20.1% -6.67%
Cash From Operating Activities $970.0K -$45.00K $920.0K
YoY Change 5.43% -102.02% -300.0%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K -$212.0K -$50.00K
YoY Change 40.0% -26.9% -61.54%
Acquisitions
YoY Change
Other Investing Activities $0.00 $314.0K $240.0K
YoY Change -100.0% -60.35%
Cash From Investing Activities -$70.00K $102.0K $200.0K
YoY Change -135.0% -79.68% -253.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.000K
YoY Change 300.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 400.0K 59.00K 60.00K
YoY Change 566.67% -103.44% -91.78%
NET CHANGE
Cash From Operating Activities 970.0K -45.00K 920.0K
Cash From Investing Activities -70.00K 102.0K 200.0K
Cash From Financing Activities 400.0K 59.00K 60.00K
Net Change In Cash 1.300M 116.0K 1.180M
YoY Change 10.17% -88.63% 742.86%
FREE CASH FLOW
Cash From Operating Activities $970.0K -$45.00K $920.0K
Capital Expenditures -$70.00K -$212.0K -$50.00K
Free Cash Flow $1.040M $167.0K $970.0K
YoY Change 7.22% -93.38% -393.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17217919
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q2 dei Entity Public Float
EntityPublicFloat
5142712
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 tssi Allowance For Doubtful Accounts Receivable Recovery Of Amounts Previously Reserved
AllowanceForDoubtfulAccountsReceivableRecoveryOfAmountsPreviouslyReserved
CY2017 tssi Allowance For Doubtful Accounts Receivable Recovery Of Amounts Previously Reserved
AllowanceForDoubtfulAccountsReceivableRecoveryOfAmountsPreviouslyReserved
CY2018Q4 tssi Deferred Tax Liabilities Net
DeferredTaxLiabilitiesNet
-14000
CY2017Q4 tssi Deferred Tax Liabilities Net
DeferredTaxLiabilitiesNet
20000
CY2018 tssi Fair Value Of Restricted Stock
FairValueOfRestrictedStock
405000
CY2018 tssi Income Tax Expense Benefit Before Valuation Allowance
IncomeTaxExpenseBenefitBeforeValuationAllowance
26000
CY2017 tssi Income Tax Expense Benefit Before Valuation Allowance
IncomeTaxExpenseBenefitBeforeValuationAllowance
9000
CY2018 tssi Operating Loss Carry Forwards Expiration Term
OperatingLossCarryForwardsExpirationTerm
P20Y
CY2018 tssi Proceeds From Divestiture Of Businesses Net
ProceedsFromDivestitureOfBusinessesNet
2144000
CY2017 tssi Proceeds From Divestiture Of Businesses Net
ProceedsFromDivestitureOfBusinessesNet
314000
CY2018 tssi Provision For Recovery Of Doubtful Accounts
ProvisionForRecoveryOfDoubtfulAccounts
CY2017 tssi Provision For Recovery Of Doubtful Accounts
ProvisionForRecoveryOfDoubtfulAccounts
-2000
CY2018 tssi Reporting Period Of Common Stock From Grant Date
ReportingPeriodOfCommonStockFromGrantDate
P20D
CY2018 tssi Shares Issued Value Exercise Of Warrants
SharesIssuedValueExerciseOfWarrants
105000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8000
CY2018Q4 tssi Surety Bonds Amount Outstanding
SuretyBondsAmountOutstanding
7300000
CY2017Q4 tssi Surety Bonds Amount Outstanding
SuretyBondsAmountOutstanding
7300000
CY2018Q4 tssi Unrestricted Cash And Cash Equivalents
UnrestrictedCashAndCashEquivalents
5900000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2390000
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2841000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
944000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1413000
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
735000
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
998000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
566000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
847000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1577000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1620000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69241000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68886000
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
296000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
241000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
68000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8000
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
CY2017 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
81000
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
34000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
115000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
143000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
324000
CY2018Q4 us-gaap Assets
Assets
9110000
CY2017Q4 us-gaap Assets
Assets
6727000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
7433000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
3729000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6178000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2268000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
26000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2152000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3910000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
116000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
49000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
49000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17520000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16316000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16743000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15547000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk</div><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We are currently economically dependent upon our relationship with a large US-based IT Original Equipment Manufacturer (OEM). If this relationship is unsuccessful or discontinues, our business and revenue will suffer. The loss of or a significant reduction in orders from this customer or the failure to provide adequate products or services to them could significantly reduce our revenue.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The following customers accounted for a significant percentage of our revenues for the periods shown:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 64%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 16%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">8</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 16%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">7</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 64%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">US-based IT OEM</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">66%</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67%</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> other customers represented more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of our revenues for any periods presented. Our US based IT OEM customer represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26%</div> of our trade accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively. A US-based UPS manufacturer represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22%</div> of our accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>A US-based technology consulting company represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23%</div> of our accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> other customer represented more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of our accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>or at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div></div></div></div></div></div></div></div>
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
154000
CY2017Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
223000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2181000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2494000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
112000
CY2017Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
CY2018 us-gaap Cost Of Services Excluding Depreciation Depletion And Amortization
CostOfServicesExcludingDepreciationDepletionAndAmortization
13852000
CY2017 us-gaap Cost Of Services Excluding Depreciation Depletion And Amortization
CostOfServicesExcludingDepreciationDepletionAndAmortization
10591000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
19000
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1995000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-6000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-4000
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
33000
CY2017Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1205000
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1665000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9580000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10708000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8154000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8792000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
12000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
12000
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
39000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
139000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
65000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
70000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
135000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9594000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10688000
CY2018Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
7000
CY2017Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
20000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
12000
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
CY2018 us-gaap Depreciation
Depreciation
263000
CY2017 us-gaap Depreciation
Depreciation
339000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
300000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
300000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
385000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
481000
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2018 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2463000
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.01
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.01
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.363
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.48
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.139
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.11
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.024
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
856000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
567000
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
314000
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P328D
CY2018 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
1140000
CY2017 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
321000
CY2018Q4 us-gaap Goodwill
Goodwill
780000
CY2017Q4 us-gaap Goodwill
Goodwill
1907000
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
1100000
CY2018 us-gaap Gross Profit
GrossProfit
8483000
CY2017 us-gaap Gross Profit
GrossProfit
7725000
CY2018 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
775000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
57000
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
43000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
369000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2474000
CY2018 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
84000
CY2017 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-316000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-126000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-324000
CY2018 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
101000
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
47000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-26000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
75000
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
67000
CY2017 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-21000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-21000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-59000
CY2018 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
478000
CY2017 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1401000
CY2018 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3147000
CY2017 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1013000
CY2018 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
CY2017 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
4000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
398000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
561000
CY2017Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
0
CY2018Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
0
CY2018 us-gaap Interest Expense
InterestExpense
403000
CY2017 us-gaap Interest Expense
InterestExpense
328000
CY2018 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-403000
CY2017 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-328000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
223000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
273000
CY2018Q4 us-gaap Inventory Net
InventoryNet
108000
CY2017Q4 us-gaap Inventory Net
InventoryNet
134000
CY2018Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
110000
CY2017Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
136000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2000
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2000
CY2018Q4 us-gaap Liabilities
Liabilities
6629000
CY2017Q4 us-gaap Liabilities
Liabilities
7032000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9110000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6727000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4571000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5335000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
1838000
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
1656000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1995000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1838000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1656000
CY2018 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
10000
CY2017 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
20000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
108000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1902000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
102000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1900000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
2437000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
766000
CY2018 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
2437000
CY2017 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
766000
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
2866000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2514000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
729000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
1106000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
194000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
807000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
784000
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
35100000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
37700000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
109000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
112000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
108000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
41000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6000
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4000
CY2018 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
242000
CY2017 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
212000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
266000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
114000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
114000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2018 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
CY2017 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1050000
CY2018 us-gaap Proceeds From Repayments Of Accounts Receivable Securitization
ProceedsFromRepaymentsOfAccountsReceivableSecuritization
CY2017 us-gaap Proceeds From Repayments Of Accounts Receivable Securitization
ProceedsFromRepaymentsOfAccountsReceivableSecuritization
-737000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1967000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2038000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
390000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
418000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000
CY2018Q4 us-gaap Purchase Obligation
PurchaseObligation
1200000
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
727000
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
990000
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
250000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65220000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67657000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22335000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18316000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6372000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6459000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
241000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
68000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1433500
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.17
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2316000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
49000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.41
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.37
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
250000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2557000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2557000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
250000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.47
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.10
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1700
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2220000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2461000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2572000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.48
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.15
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.18
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2572000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
745
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1138500
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.19
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.10
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.49
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.10
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
954
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y102D
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1340000
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2137000
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1138500
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
1760000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
17500
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.29
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.13
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.34
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.13
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.20
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y240D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y292D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y164D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1231000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.13
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
90000
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
68000
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
241000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
CY2018 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
7989
CY2017 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
20567
CY2018 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6000
CY2017 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2481000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-305000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-1431000
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
777000
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
769000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1100000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18679000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16524000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1542000
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1536000
CY2017 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4000
CY2018 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
6000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15532000
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15507000

Files In Submission

Name View Source Status
0001437749-19-005421-index-headers.html Edgar Link pending
0001437749-19-005421-index.html Edgar Link pending
0001437749-19-005421.txt Edgar Link pending
0001437749-19-005421-xbrl.zip Edgar Link pending
ex_135608.htm Edgar Link pending
ex_135609.htm Edgar Link pending
ex_135610.htm Edgar Link pending
ex_135611.htm Edgar Link pending
ex_135612.htm Edgar Link pending
ex_135613.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tssi-20181231.xml Edgar Link completed
tssi-20181231.xsd Edgar Link pending
tssi-20181231_cal.xml Edgar Link unprocessable
tssi-20181231_def.xml Edgar Link unprocessable
tssi-20181231_lab.xml Edgar Link unprocessable
tssi-20181231_pre.xml Edgar Link unprocessable
tssi20181231_10k.htm Edgar Link pending